NYSE$CHWY
Chewy · Q3 2020 earnings
Q3 2020 earnings · · Investor relations
Briefing
Chewy's Q3 2020 financial results were released, showing significant year-over-year growth in net sales and improved profitability.
Chewy reported record net sales of $1.78 billion, a 45% increase year-over-year. Gross margin expanded to 25.5%, and adjusted EBITDA improved significantly. The company's focus on execution and inventiveness drove positive results, with strategic initiatives in proprietary brands and healthcare offerings contributing to the momentum.
- Net sales reached $1.78 billion, representing a 45% increase year-over-year.
- Gross margin expanded by 180 basis points to 25.5%.
- Net loss was $32.8 million, which includes share-based compensation expense of $25.1 million.
- Adjusted EBITDA improved 118% year-over-year, reaching $5.5 million.
Headline financials
Revenue & EPS history
Chewy · Revenue · Quarterly
$1.78B
Forward guidance
No forward guidance was provided in the press release.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q3 2020
-1.0%
Avg return
Earnings day
-0.9%
Avg return
5 days after
+2.2%
Avg return
30 days after
46%
13 / 28 earnings
Positive
+27.4%
Q1 2024
Best reaction
-16.6%
Q2 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.0% | -5.2% | — | |
| Q4 2025 | +1.0% | -1.5% | — | |
| Q3 2026 | +1.5% | -4.9% | -7.7% | |
| Q2 2026 | -16.6% | -12.2% | -7.3% | |
| Q1 2025 | +0.1% | +4.5% | -5.6% | |
| Q4 2024 | -1.1% | -3.3% | +9.5% | |
| Q3 2024 | -7.6% | -8.1% | +7.0% | |
| Q2 2024 | +11.0% | +10.4% | +15.9% | |
| Q1 2024 | +27.4% | +31.6% | +61.1% | |
| Q4 2023 | -4.6% | -7.6% | -3.2% | |
| Q3 2023 | +4.4% | +10.0% | +10.9% | |
| Q2 2023 | -12.1% | -9.6% | -33.1% | |
| Q1 2023 | +18.7% | +21.9% | +30.7% | |
| Q4 2022 | -12.4% | -13.8% | -17.6% | |
| Q3 2022 | +5.9% | +8.1% | -9.0% | |
| Q2 2022 | -9.7% | -13.8% | -18.2% | |
| Q1 2022 | +17.7% | +11.9% | +50.0% | |
| Q4 2021 | -12.3% | -16.1% | -33.9% | |
| Q3 2021 | -13.9% | -8.7% | -19.3% | |
| Q2 2021 | -10.0% | -12.9% | -23.5% | |
| Q1 2021 | -3.9% | -5.0% | +10.0% | |
| Q4 2020 | +7.4% | +4.9% | +3.3% | |
| Q3 2020 | +1.1% | +13.8% | +31.0% | |
| Q2 2020 | -12.5% | -12.0% | +0.1% | |
| Q1 2020 | +1.8% | -1.3% | +6.5% | |
| Q3 2019 | +2.2% | +13.3% | +14.7% | |
| Q2 2019 | -6.7% | -13.3% | -12.1% | |
| Q1 2019 | -3.1% | -6.5% | -2.3% | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro